Stephen Gordon, Chief Financial Officer at TransMedics Group, Inc. (TMDX), sold 20,000 shares at $48.09 ($962K) on 2022-08-08, disclosed to the SEC on 2022-08-09.
Open-market sale of $962k TMDX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.09 | 10,000 | $481K | 50.0% |
| 2 | $48.09 | 10,000 | $481K | 50.0% |
| Total | $48.09 avg | 20,000 | $962K | 100% |
| Filing → |
| TMDX | SELL | 2024-05-08 | $1.9M | — | Filing → |
| TMDX | SELL | 2024-04-02 | $1.1M | — | Filing → |
| TMDX | SELL | 2024-03-12 | $334K | — | Filing → |